Atlas Trials

First-line FOLFOXIRI In Combination With Bevacizumab For Metastatic Colorectal Cancer

Clinical trial NCT01163396 · COMPLETED

Trial details

NCT number
NCT01163396
Sponsor
Gruppo Oncologico del Nord-Ovest
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Colorectal Cancer Metastatic
Start date
2007-07-01
Primary completion
2009-04-01
Enrollment
57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.